Mutsumi Mizoi
Overview
Explore the profile of Mutsumi Mizoi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
105
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yoshida M, Uemura T, Mizoi M, Waragai M, Sakamoto A, Terui Y, et al.
J Alzheimers Dis
. 2023 Feb;
92(1):361-369.
PMID: 36744340
Background: Dementia, including Alzheimer's disease (AD), is one of the serious diseases at advanced age, and its early detection is important for maintaining quality of life (QOL). Objective: In this...
2.
Yoshida M, Kato N, Uemura T, Mizoi M, Nakamura M, Saiki R, et al.
eNeurologicalSci
. 2017 Dec;
7:18-24.
PMID: 29260020
Objective: Measurement of plasma levels of protein-conjugated acrolein (PC-Acro) together with IL-6 and CRP can be used to identify silent brain infarction (SBI) with high sensitivity and specificity. The aim...
3.
Yoshida M, Kanzaki T, Mizoi M, Nakamura M, Uemura T, Mimori S, et al.
Clin Chim Acta
. 2016 Nov;
464:50-56.
PMID: 27816667
Background: We clarified the correlation between brain damage, associated biomarkers and medication in psychiatric patients, because patients with schizophrenia have an increased risk of stroke. Methods: The cross-sectional study was...
4.
Yamanaka K, Kato K, Mizoi M, An Y, Nakanao M, Hoshino M, et al.
Life Sci
. 2015 Sep;
84(17-18):627-33.
PMID: 26324994
Aims: Recent animal experiments have indicated that dimethylarsinic acid (DMA), a main metabolite of inorganic arsenic, is a complete carcinogen in the lung of mice and the urinary bladder of...
5.
Yoshida M, Higashi K, Kuni K, Mizoi M, Saiki R, Nakamura M, et al.
Clin Chim Acta
. 2014 Dec;
441:115-21.
PMID: 25542982
Background: We previously reported that the level of urinary 3-hydroxypropyl mercapturic acid (3-HPMA)/creatinine (Cre) was reduced following stroke. The aim of this study was to determine whether the level of...
6.
Mizoi M, Yoshida M, Saiki R, Waragai M, Uemura K, Akatsu H, et al.
Clin Chim Acta
. 2014 Feb;
430:150-5.
PMID: 24508996
Background: We found previously that the amyloid β40/42 (Aβ40/42) ratio and the level of protein-conjugated acrolein (PC-Acro) in plasma were increased in mild cognitive impairment (MCI) and Alzheimer's disease (AD)...
7.
Waragai M, Yoshida M, Mizoi M, Saiki R, Kashiwagi K, Takagi K, et al.
J Alzheimers Dis
. 2012 Jul;
32(1):33-41.
PMID: 22751175
The objective of this study was to determine whether plasma levels of acrolein, a compound that causes cell damage, and amyloid-β (Aβ) are useful biochemical markers for Alzheimer's disease (AD)....
8.
Yoshida M, Mikami T, Higashi K, Saiki R, Mizoi M, Fukuda K, et al.
Clin Chim Acta
. 2012 Feb;
413(7-8):753-9.
PMID: 22293277
Background: We found previously that increases in plasma levels of protein-conjugated acrolein and polyamine oxidases, enzymes that produce acrolein, are good biomarkers for stroke. The aim of this study was...
9.
Yoshida M, Mizoi M, Saiki R, Kobayashi E, Saeki N, Wakui K, et al.
Clin Chim Acta
. 2010 Nov;
412(3-4):339-42.
PMID: 21070758
Background: We have recently found that the median relative risk value (RRV) (0-1) of brain infarction estimated by protein-conjugated acrolein (PC-Acro), IL-6 and CRP together with age was in the...
10.
Yoshida M, Higashi K, Kobayashi E, Saeki N, Wakui K, Kusaka T, et al.
Atherosclerosis
. 2010 Apr;
211(2):475-9.
PMID: 20417516
Objective: We found previously that the measurement of plasma levels of protein-conjugated acrolein (PC-Acro) together with IL-6 and CRP can be used to identify silent brain infarction (SBI) with high...